Efficient electrostatic solvation model for protein-fragment docking

Proteins: Structure, Function and Genetics

Volumn 42, Issue 2, 2001, Pages 256-268

  Majeux, Nicolas ^a   Scarsi, Marco ^a   Caflisch, Amedeo ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Binding energy; First solvation shell; FKBP 12; ICE; Library docking; MDM2; p38 MAP kinase; Thrombin

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

BINDING AFFINITY; BINDING SITE; CONFERENCE PAPER; DNA LIBRARY; ELECTRICITY; MOLECULAR DYNAMICS; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROCESSING; SOLVATION; STRUCTURE ACTIVITY RELATION; VALIDATION PROCESS;

BINDING SITES; CASPASE 1; ELECTROSTATICS; LIGANDS; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, CHEMICAL; MODELS, MOLECULAR; NUCLEAR PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; REPRODUCIBILITY OF RESULTS; SOFTWARE VALIDATION; TACROLIMUS BINDING PROTEIN 1A; THROMBIN;

EID: 0035254951     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0134(20010201)42:2<256::AID-PROT130>3.0.CO;2-4     Document Type: Conference Paper

References (78)

1. Inclusion of solvation in ligand binding free energy calculations using the generalized-born model
2. Computational ligand design
3. Comment on the validation of continuum electrostatics models
4. Implicit solvent models
5. Implicit solvation models: Equilibria, structure, spectra, and dynamics
6. Calculation of the electric potential in the active site cleft due to α-helix dipoles
7. Continuum model calculations of solvation free energies: Accurate evaluation of electrostatic contributions
8. A local dielectric constant model for solvation free energies which accounts for solute polarizability
9. Accurate calculation of hydration free energies using macroscopic solvent models
10. Electrostatic contributions to solvation energies: Comparison of free energy perturbation and continuum calculation
11. Atomic radii for continuum electrostatics calculations based on molecular dynamics free energy simulations
12. Comparison of continuum and explicit models of solvation: Potential of mean force for alanine dipeptide
13. Enzyme-inhibitor association thermodynamics: Explicit and continuum solvent studies
14. Molecular dynamics simulation of melittin in a dimyristoylphosphatidylcholine bilayer membrane
15. Semianalytical treatment of solvation for molecular mechanics and dynamics
16. Pairwise solute descreening of solute charges from a dielectric medium
17. A comprehensive analytical treatment of continuum electrostatics
18. Parametrized models of aqueous free energies of solvation based on pairwise descreening of solute atomic charges from a dielectric medium
19. The GB/SA continuum model for solvation: A fast analytical method for the calculation of approximate born radii
20. Continuum electrostatic energies of macromolecules in aqueous solutions
21. Comparison of a GB solvation model with explicit solvent simulations: Potentials of mean force and conformational preferences of alanine dipeptide and 1,2-dichloroethane
22. Development of a generalized born model parametrization for proteins and nucleic acids
23. Exhaustive docking of molecular fragments on protein binding sites with electrostatic solvation
24. An alternative method for the alignment of molecular structures: Maximizing electrostatic and steric overlap
25. Hydrophobicity at the surface of proteins
26. Calculation of the total electrostatic energy of a macromolecular system: Solvation energies, binding energies, and conformational analysis
27. Computational combinatorial ligand design: Application to human α-thrombin
28. Sidechain torsional potentials and motion of amino acids in proteins: Bovine pancreatic trypsin inhibitor
29. A molecular mechanics/grid method for evaluation of ligand-receptor interactions
30. Structure-based combinatorial ligand design
31. A virtual screening approach applied to the search for trypanothione reductase inhibitors
32. Computer simulations of protein folding by targeted molecular dynamics
33. Folding simulations of a three-stranded antiparallel β-sheet peptide
34. "New view" of protein folding reconciled with the old through multiple unfolding simulations
35. The interpretation of protein structures: Estimation of static accessibility
36. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons
37. Stability of protein structure and hydrophobic interactions
38. Common features of protein unfolding and dissolution of hydrophobic compounds
39. Stability of folded conformations
40. A free energy analysis of nucleic acid base stacking in aqueous solution
41. Docking by Monte Carlo minimization with a solvation correction: Application to an FKBP-substrate complex
42. Discrimination between native and intentionally misfolded conformations of proteins: ES/IS, a new method for calculating conformational free energy that uses both dynamics simulations with an explicit solvent and an implicit solvent continuum model
43. A comparative study of ligand-receptor complex binding affinity prediction methods based on glycogen phosphorylase inhibitors
44. Energy functions for peptides and proteins. I. Derivation of a consistent force field including the hydrogen bond from amide crystals
45. Computer graphics in real-time docking with energy calculation and minimization
46. Automated docking with grid-based energy evaluation
47. Numerical recipes in fortran
48. The properties of known drugs. 1. Molecular frameworks
49. Recent advances in the solid phase synthesis of drug-like heterocyclic small molecules
50. Combinatorial libraries by portioning and mixing
51. Iterative partial equalization of orbital electronegativity: A rapid access to atomic charges
52. Determination of net atomic charges using a modified partial equalization of orbital electronegativity method. 1. Application to neutral molecules as models for polypeptides
53. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations
54. The protein data bank: A computer-based archival file for macromolecular structures
55. Energetics of charge-charge interactions in proteins
56. Solving the finite difference linearized Poisson-Boltzmann equation: A comparison of relaxation and conjugate gradient methods
57. Electrostatics and diffusion of molecules in solution: Simulations with the University of Houston Brownian dynamics program
58. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin
59. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-proly isomerase
60. The MDM-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
61. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain
62. Molecular characterization of the hdm2-p53 interaction
63. SB 203580 is a specific inhibitor of a map kinase homologue which is stimulated by cellular stresses and interleukin-1
64. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
65. Inhibitors of serine/threonine kinases
66. Structural basis of inhibitor selectivity in MAP kinases
67. Synthetic low-molecular weight thrombin inhibitors: Molecular design and pharmacological profile
68. Design and synthesis of potent and highly selective thrombin inhibitors
69. The refined 1.9-Å crystal structure of human α-thrombin: Interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment
70. Crystallographic analysis at 3.0-Å resolution of the binding to human thrombin of four active site-directed inhibitors
71. Design neuartiger, nichtpeptidischer Thrombin-Inhibitoren und Struktur eines Thrombin-Inhibitor-Komplexes
72. Small-molecule inhibitors of thrombin
73. Derivatives of 5-amidine indole as inhibitors of thrombin catalytic activity
74. Structure and mechanism of interleukin-1β converting enzyme
75. Tow-stage method for protein-ligand docking
76. Discovering high affinity ligands for proteins: SAR by NMR
77. Discovery of potent nonpeptide inhibitors of stromelysin using SAR by NMR
78. Stomelysin inhibitors designed from weakly bound fragments: Effects of linking and cooperativity